Glicksman RM, Metser U, Vines D, Valliant J, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021 Mar 5. pii: S0302-2838(21)00151.
PMID: 33685838